CRISPR: The Gene Editing Revolution | Fine Motor

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a gene editing tool that has revolutionized the field of biotechnology. Developed by scientists Jennifer Doudna and Emmanuelle Charpentier in 2012, CRISPR allows for precise editing of genes, opening up new possibilities for treating genetic diseases and improving crop yields. However, the technology has also raised concerns about ethics, safety, and unintended consequences, with some critics arguing that it could be used to create 'designer babies.' As of 2022, CRISPR has been used in over 1,000 clinical trials, with a 75% success rate in treating certain genetic disorders. Despite the controversy, CRISPR has a vibe score of 85, indicating its significant cultural energy and potential to transform the field of biotechnology. The influence flow of CRISPR can be seen in its connections to key figures such as David Liu, who has developed new CRISPR-based technologies, and companies like Editas Medicine, which is working on CRISPR-based treatments for genetic diseases.